{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:00:34Z","timestamp":1778644834756,"version":"3.51.4"},"reference-count":22,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"3","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Cyclin-dependent kinase 4\/6 inhibitors (CDK4\/6i) have redefined the standard of care for hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative advanced breast cancer (BC). However, patterns of use and access across Latin America remain poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted a cross-sectional survey of Latin American medical oncologists with experience in treating advanced BC using CDK4\/6i. The survey assessed drug availability and clinical decision making across various scenarios. Descriptive statistics were used to summarize responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 116 oncologists from 15 countries participated. Ribociclib was the preferred agent (56.8%), driven largely by its overall survival benefit across pivotal trials. Abemaciclib was favored in endocrine resistance, central nervous system metastases, and patients with cardiac or hepatic comorbidities. Palbociclib was preferred in geriatric and male patients. Despite high reported national availability of CDK4\/6i, access at the institutional level was uneven. Among oncologists working primarily in private practice, 54.3% reported that their prescribing patterns would differ if treating publicly insured patients, compared with only 22.6% of public sector oncologists who reported the opposite.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Although CDK4\/6i are accepted as essential therapies for advanced BC, substantial institutional access barriers persist in Latin America. Clinical preferences reflect both emerging evidence and local constraints. Broader integration of CDK4\/6i into public formularies and continuous generation of real-world data are critical for improving equity and outcomes in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00425","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:59:11Z","timestamp":1773950351000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Preferences in Cyclin-Dependent Kinase 4\/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin America"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-339X","authenticated-orcid":true,"given":"Cynthia","family":"Villarreal-Garza","sequence":"first","affiliation":[{"name":"Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9400-3111","authenticated-orcid":true,"given":"Andres","family":"Meraz-Brenez","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agatha","family":"Reyes Morales","sequence":"additional","affiliation":[{"name":"Hospital Roosevelt, Ciudad de Guatemala, Guatemala"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-8726","authenticated-orcid":true,"given":"Ahmad Wali","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Hospital de Especialidades Eugenio Espejo, Quito, Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brizio","family":"Moreno-Jaime","sequence":"additional","affiliation":[{"name":"Hospital Regional ISSSTE Le\u00f3n, Guanajuato, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6522-1061","authenticated-orcid":true,"given":"Denis U","family":"Landaverde","sequence":"additional","affiliation":[{"name":"Hospital Mexico, San Jose, Costa Rica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-3331","authenticated-orcid":true,"given":"Fernando E.","family":"Petracci","sequence":"additional","affiliation":[{"name":"Instituto Alexander Fleming, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-5874","authenticated-orcid":true,"given":"Henry","family":"Idrobo Quintero","sequence":"additional","affiliation":[{"name":"Hospital Universitario San Jorge de Pereira, Pereira, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3483-9654","authenticated-orcid":true,"given":"Joel","family":"Moreno R\u00edos","sequence":"additional","affiliation":[{"name":"Instituto de Oncologia Nacional, Ciudad de Panama, Panama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos Samam\u00e9","family":"P\u00e9rez-Vargas","sequence":"additional","affiliation":[{"name":"Cl\u00ednica San Felipe, Lima, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3614-7595","authenticated-orcid":true,"given":"Victor","family":"Acosta Mar\u00edn","sequence":"additional","affiliation":[{"name":"Centro Cl\u00ednico de la Mama (CECLIM), Caracas, Venezuela"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-164X","authenticated-orcid":true,"given":"William Armando","family":"Mantilla","sequence":"additional","affiliation":[{"name":"Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center, Bogota, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-8569","authenticated-orcid":true,"given":"Alejandro","family":"Aranda-Gutierrez","sequence":"additional","affiliation":[{"name":"Hematology and Oncology Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3231-1659","authenticated-orcid":true,"given":"Daniela","family":"Vazquez-Juarez","sequence":"additional","affiliation":[{"name":"Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505270"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.6155"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.7585"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609709"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30292-4"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.9909"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00137"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810527"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.4782"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114663"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911149"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903765"},{"key":"e_1_3_5_15_2","unstructured":"NCCN Clinical Practice Guidelines in oncology (NCCN guidelines\u00ae) breast cancer. 2025 https:\/\/www.nccn.org"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.019"},{"key":"e_1_3_5_17_2","article-title":"Advanced breast cancer guidelines in Latin America: Assessment, adaptation, and implementation of fifth advanced breast cancer consensus guidelines","author":"Valencia F","unstructured":"Valencia F, G\u00f3mez HL, Neciosup SP, et al: Advanced breast cancer guidelines in Latin America: Assessment, adaptation, and implementation of fifth advanced breast cancer consensus guidelines. JCO Glob Oncol 10.1200\/go.22.00067","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.1081"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30549"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61646-9"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-022-00793-7"},{"key":"e_1_3_5_23_2","article-title":"Systemic treatment of patients with metastatic breast cancer: ASCO resource\u2013stratified guideline Q and A","author":"Al Sukhun S","unstructured":"Al Sukhun S, Koczwara B, Temin S, et al: Systemic treatment of patients with metastatic breast cancer: ASCO resource\u2013stratified guideline Q and A. JCO Glob Oncol 10.1200\/go.23.00411","journal-title":"JCO Glob Oncol"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:59:14Z","timestamp":1773950354000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1200\/GO-25-00425"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00425","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500425"}}